ASD Insight™
Autism Spectrum Disorder (ASD) Risk Detection
N/A (Diagnostic)Active
Key Facts
Indication
Autism Spectrum Disorder (ASD) Risk Detection
Phase
N/A (Diagnostic)
Status
Active
Company
About NeuroQure
NeuroQure is pioneering a diagnostic paradigm shift in autism spectrum disorder through its proprietary ASD Insight™ test. The test detects a functional calcium signaling biomarker in skin cells, offering the potential for risk assessment from birth, which is significantly earlier than the current standard of care reliant on behavioral observation. This early detection is designed to enable earlier access to interventions, which studies suggest can improve developmental outcomes. The company is commercializing this test directly to patients and healthcare providers, positioning itself at the intersection of diagnostics, personalized medicine, and neurodevelopmental health.
View full company profile